We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
+1.69%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$353M
AUM Growth
+$22.9M
Cap. Flow
+$20.2M
Cap. Flow %
5.72%
Top 10 Hldgs %
40.34%
Holding
104
New
6
Increased
21
Reduced
24
Closed
10

Top Buys

Rank Stock Value
1
NOC icon
Northrop Grumman
NOC
+$7.97M
2
JPM icon
JPMorgan Chase
JPM
+$7.83M
3
ABBV icon
AbbVie
ABBV
+$6.04M
4
NVDA icon
NVIDIA
NVDA
+$4.32M
5
XLNX
Xilinx Inc
XLNX
+$4.13M

Sector Composition

Rank Sector Weight
1 Healthcare 30.55%
2 Technology 17.29%
3 Communication Services 13.62%
4 Industrials 12.57%
5 Energy 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KO icon
51
Coca-Cola
KO
$386B
$917K 0.26%
18,000
WRK
52
DELISTED
WestRock Company
WRK
$908K 0.26%
24,888
LLL
53
DELISTED
L3 Technologies, Inc.
LLL
$736K 0.21%
3,000
MDSO
54
DELISTED
Medidata Solutions, Inc.
MDSO
$670K 0.19%
7,400
TROW icon
55
T. Rowe Price
TROW
$23.7B
$651K 0.18%
5,930
PH icon
56
Parker-Hannifin
PH
$125B
$634K 0.18%
3,727
ICPT
57
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$633K 0.18%
7,954
+354
+5% +$31.7K
FWONA icon
58
Liberty Media Series A
FWONA
$23.4B
$608K 0.17%
17,710
-1,017
-5% -$35.5K
GILD icon
59
Gilead Sciences
GILD
$181B
$534K 0.15%
7,907
ET icon
60
Energy Transfer Partners
ET
$73.4B
$530K 0.15%
37,622
MSFT icon
61
Microsoft
MSFT
$3.81T
$496K 0.14%
3,703
-300
-7% -$38.1K
CVS icon
62
CVS Health
CVS
$119B
$460K 0.13%
8,450
LBRDA
63
DELISTED
Liberty Broadband Class A
LBRDA
$444K 0.13%
4,316
-974
-18% -$95.7K
NGVT icon
64
Ingevity
NGVT
$2.39B
$436K 0.12%
4,147
LSXMK
65
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$406K 0.11%
14,049
TXN icon
66
Texas Instruments
TXN
$236B
$399K 0.11%
3,475
DISH
67
DELISTED
DISH Network Corp.
DISH
$392K 0.11%
10,200
RCM
68
DELISTED
R1 RCM Inc. Common Stock
RCM
$377K 0.11%
30,000
BLUE
69
DELISTED
bluebird bio
BLUE
$356K 0.1%
+216
New +$374K
FWONK icon
70
Liberty Media Series C
FWONK
$25.5B
$314K 0.09%
8,671
-2,017
-19% -$73.1K
LADR
71
Ladder Capital
LADR
$1.25B
$304K 0.09%
18,278
AEP icon
72
American Electric Power
AEP
$66.6B
$296K 0.08%
3,358
-4,300
-56% -$371K
GS icon
73
Goldman Sachs
GS
$301B
$292K 0.08%
1,425
SPY icon
74
State Street SPDR S&P 500 ETF Trust
SPY
$825B
$285K 0.08%
973
XLK icon
75
State Street Technology Select Sector SPDR ETF
XLK
$121B
$283K 0.08%
7,242

Similar funds

Private Capital Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Private Capital Advisors held 104 positions worth $353M, up 6.9% from $330M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Private Capital Advisors deployed $20.2M of net new capital in Q2 2019, opening 6 new positions and adding to 21 existing holdings. Its largest new stake was Northrop Grumman: 26,750 shares worth $8.64M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 31% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was ExxonMobil, an estimated $1.25M trimmed.

  • Private Capital Advisors's largest Q2 2019 buy was Northrop Grumman: 26,750 shares worth $8.64M.
  • Private Capital Advisors added most to AbbVie in Q2 2019, an estimated $6.04M increase.
  • Private Capital Advisors's biggest Q2 2019 reduction was ExxonMobil, cutting an estimated $1.25M.
  • Private Capital Advisors fully exited iShares Biotechnology ETF in Q2 2019, selling an estimated $8.91M.
  • Private Capital Advisors's ten largest holdings make up 40% of its $353M portfolio in Q2 2019.
  • Private Capital Advisors opened 6 new positions and closed 10 in Q2 2019.
  • Private Capital Advisors's portfolio value rose 6.9% quarter-over-quarter to $353M.

Based on Private Capital Advisors's 13F filing for Q2 2019, filed 18 Jul 2019.